Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Th1/Th2/Th17/TREG Response and TLRs Activation/KIR Receptors for Predicting the Evolution of the SARS Cov-2 Infected Patients

NCT04403061 is registered in ClinicalTrials.gov with Asociacion para el Estudio de las Enfermedades Infecciosas as lead sponsor.

NCT NCT04403061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04403061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Th1/Th2/Th17/TREG Response and TLRs Activation/KIR Receptors for Predicting the Evolution of the SARS Cov-2 Infected Patients
Lead sponsor
Asociacion para el Estudio de las Enfermedades Infecciosas
Phase
Observational
Overall status
Completed
Start date
May 22, 2020
Completion date
January 10, 2021
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytokine release syndrome, disease, viral, tlrs